LH

美国控股实验室
NYSE

实时行情|Nasdaq Last Sale

167.42
-0.12
-0.07%
盘后: 167.42 0 0.00% 16:53 12/11 EST
开盘
167.87
昨收
167.54
最高
168.13
最低
166.38
成交量
55.72万
成交额
--
52周最高
178.44
52周最低
119.38
市值
163.07亿
市盈率(TTM)
21.20
分时
5日
1月
3月
1年
5年

分析师评级

19位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

LH 新闻

  • Does Laboratory Corporation of America Holdings's (NYSE:LH) Share Price Gain of 66% Match Its Business Performance?
  • Simply Wall St..6天前
  • U.S. FDA clears Israeli startup Sight Diagnostics' finger prick blood test
  • Reuters.12/04 17:00
  • LabCorp Announces Early Results of Its Tender Offer for up to $300,000,000 Principal Amount of Its Outstanding 4.625% Senior Notes Due 2020
  • Business Wire.12/03 13:45
  • IHF: Most Signs Point To Lower Profits For Healthcare Providers
  • Seeking Alpha - Article.12/03 08:14

更多

所属板块

医疗设施与服务
-0.04%
医疗保健提供商与服务
-0.08%

热门股票

名称
价格
涨跌幅

LH 简况

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.
展开

Webull提供Laboratory Corp. of America Holdings的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。